Cancer drug trials 'show remarkable result': Correction
XENOVA, the biotechnology company, was last month floated on the Nasdaq stock market in New York, and not on the New York Stock Exchange in our story about a new drug for cancer.
Subscribe to Independent Premium to bookmark this article
Want to bookmark your favourite articles and stories to read or reference later? Start your Independent Premium subscription today.
Already subscribed? Log in
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies